Gemini Clinical Trial Site 19 — Indianapolis, Indiana

Gemini Clinical Trial Site 19 is a clinical research site located in Indianapolis, Indiana, United States 46290.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Gemini Clinical Trial Site 19 has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Sponsors: Gemini Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gemini Clinical Trial Site 19?

Gemini Clinical Trial Site 19 has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gemini Clinical Trial Site 19 conducted?

Gemini Clinical Trial Site 19 has 1 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Is Gemini Clinical Trial Site 19 accredited by Crixeo Health?

Gemini Clinical Trial Site 19 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gemini Clinical Trial Site 19?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.